Annual Total Liabilities
$4.19 M
+$984.10 K+30.68%
December 31, 2023
Summary
- As of March 5, 2025, CNTX annual total liabilities is $4.19 million, with the most recent change of +$984.10 thousand (+30.68%) on December 31, 2023.
- During the last 3 years, CNTX annual total liabilities has fallen by -$13.20 million (-75.89%).
- CNTX annual total liabilities is now -82.70% below its all-time high of $24.23 million, reached on December 31, 2019.
Performance
CNTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.47 M
+$867.90 K+54.10%
September 30, 2024
Summary
- As of March 5, 2025, CNTX quarterly total liabilities is $2.47 million, with the most recent change of +$867.90 thousand (+54.10%) on September 30, 2024.
- Over the past year, CNTX quarterly total liabilities has stayed the same.
- CNTX quarterly total liabilities is now -90.29% below its all-time high of $25.47 million, reached on September 30, 2021.
Performance
CNTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CNTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.7% | 0.0% |
| 3 y3 years | -75.9% | 0.0% |
| 5 y5 years | -82.7% | 0.0% |
CNTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.2% | -46.3% | +54.1% |
| 5 y | 5-year | -82.7% | +38.2% | -90.3% | +54.1% |
| alltime | all time | -82.7% | +38.2% | -90.3% | +54.1% |
Context Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.47 M(+54.1%) |
| Jun 2024 | - | $1.60 M(-38.5%) |
| Mar 2024 | - | $2.61 M(-37.8%) |
| Dec 2023 | $4.19 M(+30.7%) | $4.19 M(-9.0%) |
| Sep 2023 | - | $4.60 M(+22.5%) |
| Jun 2023 | - | $3.76 M(+16.2%) |
| Mar 2023 | - | $3.23 M(+0.8%) |
| Dec 2022 | $3.21 M | $3.21 M(-20.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $4.01 M(+31.6%) |
| Jun 2022 | - | $3.05 M(+86.0%) |
| Mar 2022 | - | $1.64 M(-46.0%) |
| Dec 2021 | $3.03 M(-82.6%) | $3.03 M(-88.1%) |
| Sep 2021 | - | $25.47 M(+1.8%) |
| Jun 2021 | - | $25.02 M(+26.8%) |
| Mar 2021 | - | $19.73 M(+13.5%) |
| Dec 2020 | $17.39 M(-28.2%) | $17.39 M |
| Dec 2019 | $24.23 M | - |
FAQ
- What is Context Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Context Therapeutics?
- What is Context Therapeutics annual total liabilities year-on-year change?
- What is Context Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Context Therapeutics?
- What is Context Therapeutics quarterly total liabilities year-on-year change?
What is Context Therapeutics annual total liabilities?
The current annual total liabilities of CNTX is $4.19 M
What is the all time high annual total liabilities for Context Therapeutics?
Context Therapeutics all-time high annual total liabilities is $24.23 M
What is Context Therapeutics annual total liabilities year-on-year change?
Over the past year, CNTX annual total liabilities has changed by +$984.10 K (+30.68%)
What is Context Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CNTX is $2.47 M
What is the all time high quarterly total liabilities for Context Therapeutics?
Context Therapeutics all-time high quarterly total liabilities is $25.47 M
What is Context Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CNTX quarterly total liabilities has changed by $0.00 (0.00%)